1. Home
  2. SPHL vs BGLC Comparison

SPHL vs BGLC Comparison

Compare SPHL & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPHL
  • BGLC
  • Stock Information
  • Founded
  • SPHL 2002
  • BGLC 2017
  • Country
  • SPHL Singapore
  • BGLC Malaysia
  • Employees
  • SPHL N/A
  • BGLC N/A
  • Industry
  • SPHL Homebuilding
  • BGLC Medical Specialities
  • Sector
  • SPHL Consumer Discretionary
  • BGLC Health Care
  • Exchange
  • SPHL Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • SPHL 10.0M
  • BGLC 10.4M
  • IPO Year
  • SPHL 2024
  • BGLC N/A
  • Fundamental
  • Price
  • SPHL $0.44
  • BGLC $4.55
  • Analyst Decision
  • SPHL
  • BGLC
  • Analyst Count
  • SPHL 0
  • BGLC 0
  • Target Price
  • SPHL N/A
  • BGLC N/A
  • AVG Volume (30 Days)
  • SPHL 982.1K
  • BGLC 133.5K
  • Earning Date
  • SPHL 12-29-2025
  • BGLC 11-14-2025
  • Dividend Yield
  • SPHL N/A
  • BGLC N/A
  • EPS Growth
  • SPHL N/A
  • BGLC N/A
  • EPS
  • SPHL N/A
  • BGLC N/A
  • Revenue
  • SPHL $5,956,226.00
  • BGLC $9,465,006.00
  • Revenue This Year
  • SPHL N/A
  • BGLC N/A
  • Revenue Next Year
  • SPHL N/A
  • BGLC N/A
  • P/E Ratio
  • SPHL N/A
  • BGLC N/A
  • Revenue Growth
  • SPHL N/A
  • BGLC 2.21
  • 52 Week Low
  • SPHL $0.35
  • BGLC $2.01
  • 52 Week High
  • SPHL $7.80
  • BGLC $15.60
  • Technical
  • Relative Strength Index (RSI)
  • SPHL 41.03
  • BGLC 36.17
  • Support Level
  • SPHL $0.40
  • BGLC $4.36
  • Resistance Level
  • SPHL $0.47
  • BGLC $5.41
  • Average True Range (ATR)
  • SPHL 0.12
  • BGLC 0.28
  • MACD
  • SPHL -0.02
  • BGLC -0.08
  • Stochastic Oscillator
  • SPHL 9.71
  • BGLC 20.71

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: